BB-008 / Bullet Bio 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   0 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BB-008 / Bullet Bio
NCT06143007: A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors

Recruiting
1
42
RoW
BB3008 tablet, BB3008
BrodenBio Co., Ltd.
Advanced Solid Tumor
11/25
04/26

Download Options